{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T08:51:08Z","timestamp":1769763068989,"version":"3.49.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007684","name":"Asahi Glass Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.pnpbp.2017.06.033","type":"journal-article","created":{"date-parts":[[2017,7,8]],"date-time":"2017-07-08T06:30:51Z","timestamp":1499495451000},"page":"205-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"PC","title":["Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs"],"prefix":"10.1016","volume":"80","author":[{"given":"Buranee","family":"Kanchanatawan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9312-3469","authenticated-orcid":false,"given":"Sunee","family":"Sirivichayakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 F.","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Galecki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Maes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2017.06.033_bb0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mehy.2010.08.029","article-title":"Neuronal-immune interactions in mediating stress effects in the etiology and course of schizophrenia: role of the amygdala in developmental co-ordination","volume":"76","author":"Anderson","year":"2011","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0010","article-title":"How immune-inflammatory processes link CNS and psychiatric disorders: classification and treatment implications","author":"Anderson","year":"2016","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1178646917691738","article-title":"The interactions of tryptophan and its catabolites with melatonin and the alpha 7 nicotinic receptor in CNS and psychiatric disorders: role for the aryl hydrocarbon receptor and direct mitochondria regulation","volume":"10","author":"Anderson","year":"2017","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pnpbp.2012.07.016","article-title":"Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways","volume":"42","author":"Anderson","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0025","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/acps.12182","article-title":"Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome","volume":"129","author":"Anderson","year":"2014","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0030","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2174\/1381612822666151214105314","article-title":"Bipolar disorder: The role of the kynurenine and melatonergic pathways","volume":"22","author":"Anderson","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0035","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1982.04290070025006","article-title":"Negative v positive schizophrenia. Definition and validation","volume":"39","author":"Andreasen","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0040","first-page":"17","article-title":"Effects of various kynurenine metabolites on respiratory parameters of rat brain, liver and heart mitochondria","volume":"9","author":"Baran","year":"2016","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0269881108089583","article-title":"Kynurenine pathway in psychosis: evidence of increased tryptophan degradation","volume":"23","author":"Barry","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0050","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbi.2014.07.012","article-title":"A role for inflammatory metabolites as modulators of the glutamate N-methyl-d-aspartate receptor in depression and suicidality","volume":"43","author":"Bay-Richter","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0055","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0060","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00001504-200011000-00034","article-title":"Psychological and behavioural effects of interferons","volume":"13","author":"Bonaccorso","year":"2000","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0065","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00004714-200202000-00014","article-title":"Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system","volume":"22","author":"Bonaccorso","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0070","series-title":"Mental and Behavioural Disorders and Diseases of the Nervous System, Trending Topics in Multiple Sclerosis","article-title":"Intrathecal immunoglobulin synthesis in MS - A complete reappraisal","author":"Bonnan","year":"2016"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0075","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.4049\/jimmunol.164.6.3283","article-title":"The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and -1 beta in macrophages","volume":"164","author":"Bosco","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0080","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12640-009-9051-z","article-title":"Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons","volume":"16","author":"Braidy","year":"2009","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0085","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/0004867414533012","article-title":"Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries","volume":"48","author":"Davis","year":"2014","journal-title":"Aust. N. Z. J. Psychiatry."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neubiorev.2016.03.017","article-title":"A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis","volume":"65","author":"Davis","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0095","first-page":"2010","article-title":"Circulating antibodies to IDO\/THO pathway metabolites in Alzheimer's disease","volume":"15","author":"Duleu","year":"2010","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0100","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4088\/JCP.v60n1105","article-title":"Depressive and anxiety symptoms in patients with schizophrenia and schizophreniform disorder","volume":"60","author":"Emsley","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0105","doi-asserted-by":"crossref","first-page":"17799","DOI":"10.1038\/srep17799","article-title":"Xanthurenic acid activates mGlu2\/3 metabotropic glutamate receptors and is a potential trait marker for schizophrenia","volume":"5","author":"Fazio","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0110","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1210\/jc.2015-3076","article-title":"Gut microbiota interacts with brain microstructure and function","volume":"100","author":"Fernandez-Real","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0115","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1469-7610.2010.02245.x","article-title":"The possible role of the kynurenine pathway in adolescent depression with melancholic features","volume":"51","author":"Gabbay","year":"2010","journal-title":"J. Child Psychol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0120","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0135","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m test for nicotine dependence: a revision of the Fagerstr\u00f6m tolerance questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0140","first-page":"638","article-title":"The clinical significance of an elevated excretion of xanthurenic acid in psychiatric patients","volume":"79","author":"Hoes","year":"1979","journal-title":"Acta Psychiatr. Belg."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0145","article-title":"Deficit, but not nondeficit, schizophrenia is characterized by mucosa-associated activation of the tryptophan catabolite (TRYCAT) pathway with highly specific increases in IgA responses directed to picolinic, xanthurenic, and quinolinic acid","author":"Kanchanatawan","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0150","article-title":"Deficit schizophrenia is characterized by defects in IgM-mediated responses to tryptophan catabolites (TRYCATs): a paradigm shift toward defects in natural self-regulatory immune responses coupled with mucosa-derived TRYCAT pathway activation","author":"Kanchanatawan","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0155","article-title":"Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition","author":"Kanchanatawan","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0160","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0165-1781(86)90011-9","article-title":"Negative symptom rating scale: limitations in psychometric and research methodology","volume":"19","author":"Kay","year":"1986","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0165","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.psychres.2011.10.006","article-title":"Evaluation of the factor structure of symptoms in patients with schizophrenia","volume":"197","author":"Kim","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0170","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0165-1781(89)90153-4","article-title":"The schedule for the deficit syndrome: an instrument for research in schizophrenia","volume":"30","author":"Kirkpatrick","year":"1989","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0175","article-title":"Secondary negative symptoms - a review of mechanisms, assessment and treatment","author":"Kirschner","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0180","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1471-4159.2002.00955.x","article-title":"Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain","volume":"82","author":"Kita","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0185","series-title":"The Validity of the Mini International Neuropsychiatric Interview (M.I.N.I.)","author":"Kittirathanapaiboon","year":"2005"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0190","first-page":"389","article-title":"Impact of different antipsychotics on cytokines and tryptophan metabolites in stimulated cultures from patients with schizophrenia","volume":"25","author":"Krause","year":"2013","journal-title":"Psychiatr. Danub."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0195","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jad.2011.10.014","article-title":"A systematic review of instruments to measure depressive symptoms in patients with schizophrenia","volume":"140","author":"Lako","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0200","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pbb.2010.12.008","article-title":"Evidence for a key role of the peripheral kynurenine pathway in the modulation of anxiety- and depression-like behaviours in mice: focus on individual differences","volume":"98","author":"Laugeray","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0205","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.psychres.2010.07.013","article-title":"Decreased plasma tryptophan and tryptophan\/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: relationship to plasma cortisol concentration","volume":"185","author":"Lee","year":"2011","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0210","series-title":"Negative Versus Positive Schizophrenia","first-page":"109","article-title":"Negative symptoms in schizophrenia: relationship to positive symptoms and outcome","author":"Lieberman","year":"1991"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0215","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000284896","article-title":"Psychopathology of schizophrenia: initial validation of a 5-factor model","volume":"28","author":"Lindenmayer","year":"1995","journal-title":"Psychopathology"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0220","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/schbul\/sbq086","article-title":"Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia","volume":"38","author":"Linderholm","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0225","doi-asserted-by":"crossref","first-page":"104024","DOI":"10.1155\/2013\/104024","article-title":"Quinolinic acid: an endogenous neurotoxin with multiple targets","volume":"2013","author":"Lugo-Huitr\u00f3n","year":"2013","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0230","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jad.2016.11.039","article-title":"Biological mechanisms of depression following treatment with interferon for chronic hepatitis C: a critical systematic review","volume":"209","author":"Machado","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0235","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.psychres.2011.09.029","article-title":"Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway","volume":"196","author":"Maes","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0240","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0165-1781(93)90102-M","article-title":"Relationships between lower plasma l-tryptophan levels and immune-inflammatory variables in depression","volume":"49","author":"Maes","year":"1993","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0245","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-0447.1994.tb01527.x","article-title":"Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine","volume":"89","author":"Maes","year":"1994","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0250","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0022-3956(94)00049-W","article-title":"Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers","volume":"29","author":"Maes","year":"1995","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0255","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1017\/S0033291701004007","article-title":"Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression","volume":"31","author":"Maes","year":"2001","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0260","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/S0024-3205(02)01853-2","article-title":"Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation","volume":"71","author":"Maes","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0265","first-page":"615","article-title":"Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins","volume":"27","author":"Maes","year":"2006","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0270","first-page":"826","article-title":"The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation","volume":"28","author":"Maes","year":"2007","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0275","first-page":"264","article-title":"Somatization, but not depression, is characterized by disorders in the tryptophan catabolite (TRYCAT) pathway, indicating increased indoleamine 2,3-dioxygenase and lowered kynurenine aminotransferase activity","volume":"32","author":"Maes","year":"2011","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0280","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0285","first-page":"10","article-title":"Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways","volume":"29","author":"Maes","year":"2012","journal-title":"BMC Med."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0290","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jad.2012.06.039","article-title":"Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: Implications for the pathways to chronic depression and neuroprogression","volume":"149","author":"Maes","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0295","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/QAI.0000000000000062","article-title":"Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans","volume":"65","author":"Martinez","year":"2014","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0300","series-title":"Negative Versus Positive Schizophrenia","first-page":"71","article-title":"Methodological problems in identifying and measuring first-rank symptoms of schizophrenia","author":"Mellor","year":"1991"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0305","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.nbd.2003.12.015","article-title":"Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia","volume":"15","author":"Miller","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0310","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2174\/1381612822666151215102420","article-title":"The many neuroprogressive actions of tryptophan catabolites (TRYCATs) that may be associated with the pathophysiology of neuro-immune disorders","volume":"22","author":"Morris","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0315","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.schres.2015.01.026","article-title":"Effects of depression on the cytokine profile in drug na\u00efve first-episode psychosis","volume":"164","author":"Noto","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0320","doi-asserted-by":"crossref","DOI":"10.1007\/s12035-015-9489-3","article-title":"Depression, cytokine, and cytokine by treatment interactions modulate gene expression in antipsychotic na\u00efve first episode psychosis","author":"Noto","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0325","doi-asserted-by":"crossref","DOI":"10.1097\/PSY.0000000000000352","article-title":"Kynurenine and tryptophan levels in patients with schizophrenia with elevated ANTIGLIADIN immunoglobulin G antibodies","author":"Okusaga","year":"2016","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0330","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/bdi.12009","article-title":"Cerebrospinal fluid kynurenic acid is associated with manic and psychotic features in patients with bipolar I disorder","volume":"14","author":"Olsson","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0335","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8457612","article-title":"Are anxiety disorders associated with accelerated aging? A focus on neuroprogression","volume":"2016","author":"Perna","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0340","doi-asserted-by":"crossref","DOI":"10.2174\/1871527316666170407145533","article-title":"IgA\/IgM responses to Gram-negative bacteria are not associated with prenatal depression, but with physio-somatic symptoms and activation of the tryptophan catabolite pathway at the end of term and postnatal anxiety","author":"Roomruangwong","year":"2017","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0345","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1007\/s12035-016-9877-3","article-title":"IgA\/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome","volume":"54","author":"Roomruangwong","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0350","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.yhbeh.2012.03.010","article-title":"Indoleamine 2,3-dioxygenase mediates anhedonia and anxiety-like behaviors caused by peripheral lipopolysaccharide immune challenge","volume":"62","author":"Salazar","year":"2012","journal-title":"Horm. Behav."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0355","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","article-title":"Increased cortical kynurenate content in schizophrenia","volume":"50","author":"Schwarcz","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.pnpbp.2017.06.033_bb0360","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2249.2009.04026.x","article-title":"Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation","volume":"158","author":"Schwartz-Albiez","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0365","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1503\/jpn.140126","article-title":"Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia\u2014significance for activation of the kynurenine pathway","volume":"40","author":"Schwieler","year":"2015","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0370","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0306-9877(95)90062-4","article-title":"The macrophage-T-lymphocyte theory of schizophrenia: additional evidence","volume":"45","author":"Smith","year":"1995","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0375","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.2174\/1381612033454397","article-title":"Regulation of the immune response by natural IgM: lessons from warm autoimmune hemolytic anemia","volume":"9","author":"Stahl","year":"2003","journal-title":"Curr. Pharm. Des."},{"issue":"7","key":"10.1016\/j.pnpbp.2017.06.033_bb0395","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3109\/15622975.2011.583941","article-title":"Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood-brain barrier integrity","volume":"13","author":"Steiner","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0380","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.schres.2005.09.002","article-title":"Factor structure and external validity of the PANSS revisited","volume":"82","author":"Van den Oord","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0385","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0090-1229(85)90092-3","article-title":"Immunoglobulin G, A, and M\u2014clonal restriction in multiple sclerosis cerebrospinal fluid and serum\u2014analysis by two-dimensional electrophoresis","volume":"35","author":"Walsh","year":"1985","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.pnpbp.2017.06.033_bb0390","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584617301999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584617301999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T16:26:04Z","timestamp":1659198364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584617301999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":79,"alternative-id":["S0278584617301999"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.06.033","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Depressive, anxiety and hypomanic symptoms in schizophrenia may be driven by tryptophan catabolite (TRYCAT) patterning of IgA and IgM responses directed to TRYCATs","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2017.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}